SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience

Saha, P; Sandhu, V; Robinson, H; Ezeonyeji, A; Al-Shakarchi, I; Chander, S; Suresh, R; Kaul, A; Sofat, N (2020) Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience. In: British Society for Rheumatology Annual Conference 2020, RHEUMATOLOGY.
SGUL Authors: Sofat, Nidhi

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (22kB)
Item Type: Conference or Workshop Item (UNSPECIFIED)
Additional Information: This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record Pratyasha Saha, Virinderjit Sandhu, Helena Robinson, Amara Ezeonyeji, Israa Al-Shakarchi, Sumeet Chander, Resmy Suresh, Arvind Kaul, Nidhi Sofat, P184 Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience, Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.179 is available online at: https://doi.org/10.1093/rheumatology/keaa111.179
Keywords: Arthritis & Rheumatology, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: RHEUMATOLOGY
Article Number: keaa111.179
ISSN: 1462-0324
Dates:
DateEvent
20 April 2020Published
29 January 2020Accepted
Publisher License: Publisher's own licence
URI: https://openaccess.sgul.ac.uk/id/eprint/111884
Publisher's version: https://doi.org/10.1093/rheumatology/keaa111.179

Actions (login required)

Edit Item Edit Item